Talaris Therapeutics Inc(NASDAQ:TALS) 
Talaris Therapeutics, Inc. is a late-clinical stage biopharmaceutical company developing investigational, one-time, allogeneic cell therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant bloo...
Website: https://talaristx.com/
Founded: 1998
CEO: Scott Requadt
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-08-22
P
O 14.55
H 14.55
L 13.96
C 14.24
V 78,026
10EMA 14.24
20EMA 14.24
60EMA 14.24
120EMA 14.24
250EMA 14.24